Back to COVID-19 & Impact on Startups, Venture Capital & Public Markets.
Why Aren't We Using Experimental Drugs to Cure This Coronavirus
We have not done proper medical studies to validate if these drugs actually work and what we have is anecdotal evidence collected by doctors on the front-lines. We don't know what the short and long-term side effects are.
COVID-19 & Impact on Startups, Venture Capital & Public Markets ·
From the transcript
okay? What faith UCI and others have said and doctors around the country echo is that these treatments have not been clinically tested through a blinded controlled study, and that is a very fair research and generally speaking for doing good medicine. But we're in a crisis state, and in a crisis state, you have to triage, and you also have to triage policy, and we should be considering creating policy and changing the way that we do policy under these extenuating circumstances.
If doing treatment can reduce fatality rates by up to four X, as Korean doctors have claimed, it is worth taking the risk. Or perhaps it is worth letting the FDA say rendez severe Kaletra, Claure, Quinn and others are being widely produced, widely distributed. The government is mandating it, and doctors and their patients can decide if and when they want to use it and let them take the risk without clinical trials and without data and the typical process of the FDA.